Oruka Therapeutics Cash Flow Statement (2010-2026) | ORKA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-4.83M	-4.71M	-5.68M	-3.27M	-3.15M	-2.33M	-1.17M	-1.35M	-1.48M	-1.42M	-1.09M	-2.01M	-2.68M
Depreciation and Depletion (Quarter)															0.02M	0.02M	0.02M	0.02M	0.03M	0.04M
Share-based Compensation (Quarter)	0.13M	0.10M	0.12M	0.17M	0.17M	0.10M	0.12M	0.20M	0.19M	0.15M	0.14M	0.10M	0.68M	9.00M	5.15M	4.88M	5.08M	10.16M	4.12M	6.97M
Gains from Sales and Divestitures (Quarter)											0.09M			3.05M		0.58M	0.14M	0.85M	1.01M	0.13M
Gains from Investment Securities (Quarter)	0.15M	0.17M	-0.08M	0.03M	0.01M	0.19M		0.04M	0.62M	0.09M	0.62M	0.65M	0.05M	1.29M		0.06M	2.10M	0.03M	-1.35M	1.48M
Non-cash Items (Quarter)	0.10M	0.13M	1.90M	0.22M	0.29M	0.34M	0.02M	0.36M	0.37M	0.41M	0.37M	0.50M	0.51M	0.68M	15.47M	4.70M	0.47M	0.73M	69.97M	160.99M
Change in Working Capital (Quarter)
Cash from Operations (Quarter)	-3.72M	-4.87M	-4.95M	-4.30M	-2.62M	-2.50M	-1.49M	-1.59M	-0.69M	-1.67M	-1.06M	-0.17M	-11.03M	-27.82M	-18.82M	-20.87M	-23.13M	-21.60M	-22.61M	-23.58M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.03M	0.03M	0.03M	0.02M	0.02M	0.01M			1.80M	1.50M	1.04M	0.66M	0.45M
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)	0.00M	0.01M	0.01M	0.01M	0.01M	0.00M	0.01M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M		0.02M	0.02M	0.02M	0.02M	0.03M	0.04M
Change in Working Capital
Change in Account Payables (Quarter)	0.60M	-1.07M	-0.01M	-0.10M	0.10M	-0.52M	-0.26M	0.03M	-0.12M	0.08M	0.04M	5.83M	-3.81M	-0.40M	4.40M	0.08M	-5.99M	4.65M	-4.76M	-0.49M
Change in Accured Expenses (Quarter)	0.27M	0.58M	-0.80M	-0.76M	0.62M	-0.46M	-0.34M	0.06M	-0.04M	-0.12M	0.03M	0.77M	0.19M	0.69M	1.64M	2.32M	-2.08M	4.81M	2.21M	-1.30M
Change in Taxes (Quarter)
Other Working Capital Changes (Quarter)	-0.14M	-0.26M	-0.28M	0.41M	-0.26M	-0.61M	-0.36M	0.60M	-0.25M	-0.20M	-0.24M	0.61M	-0.60M	1.98M	-1.99M	0.15M	0.62M	2.40M	0.81M	-0.46M
Investing Activities
Capital Expenditures (Quarter)	0.01M	0.03M	0.01M	0.00M											0.02M	0.01M	0.03M	0.10M	0.06M	0.07M
Sales of Property, Plant and Equipment (Quarter)
Change in Intangibles (Quarter)
Change in Acquisitions & Divestments (Quarter)																87.17M	112.89M	145.33M	79.03M	76.47M
Cash from Investing Activities (Quarter)	-0.02M	-0.01M	-0.01M	-0.00M										-0.17M	-329.96M	42.87M	4.86M	-122.45M	-22.02M	-14.44M
Financing Activities
Other financing activities (Quarter)												0.10M	1.49M	226.54M	-0.17M
Cash from Financing Activities (Quarter)												27.91M	-1.59M	423.74M	-0.53M			169.91M	0.30M	40.60M
Additional items
Change in Cash (Quarter)	-3.74M	-4.88M	-4.95M	-4.30M	-2.62M	-2.50M	-1.49M	-1.59M	-0.69M	-1.67M	-1.06M	27.74M	-12.62M	395.75M	-349.30M	22.00M	-18.18M	25.86M	-44.32M	2.58M
Free Cash Flow (Quarter)	-3.73M	-4.90M	-4.95M	-4.30M	-2.62M	-2.50M	-1.49M	-1.59M	-0.69M	-1.67M	-1.06M	-0.17M	-11.03M	-27.82M	-18.84M	-20.88M	-23.16M	-21.70M	-22.67M	-23.65M
Net Cash Flow (Quarter)	-3.74M	-4.88M	-4.95M	-4.30M	-2.62M	-2.50M	-1.49M	-1.59M	-0.69M	-1.67M	-1.06M	27.74M	-12.62M	395.75M	-349.30M	22.00M	-18.27M	25.86M	-44.33M	2.58M

Research Tools

Oruka Therapeutics Cash Flow Statement (2010-2026) | ORKA

Create an account

Sign In

Reset Password